Fundraising Fox
🦊/People
Sign in

Benjamin Kreitman

Investor

Principal at Broadview Ventures

Cambridge, Massachusetts

Writes $100K – $5M checks · typically $1.5M

Find your path to Benjamin

250 people in our graph share verified history with Benjamin — schools, employers, funds. One of them is your warm intro.

Salim HassadunlockedBenjamin: together at Columbia University (2014)
×10Benjamin: together at Columbia University
Benjamin: together at AtaCor Medical, Inc.

About

Principal on the Biopharma team sharing responsibility for sourcing, diligence, and portfolio board work. Previously a consultant at Monitor Deloitte.

Contact· self-published, not guessed

Experience

  1. Broadview Ventures IncPrincipalcurrent2021 — present
  2. Broadview Ventures IncSenior Associate2019 — 2021
  3. Broadview Ventures IncAssociate2017 — 2019
  4. Longview VenturesPrincipalcurrent2019 — present
  5. Alveron PharmaBoard Membercurrent2024 — present
  6. Isomab LtdBoard Observercurrent2024 — present
  7. CardiosenseBoard Observercurrent2022 — present
  8. HAYA Therapeutics SABoard Membercurrent2020 — present
  9. AtaCor Medical, Inc.Board Observercurrent2018 — present
  10. Monitor DeloitteConsultant2016 — 2017
  11. Monitor DeloitteBusiness Analyst2014 — 2016

Investments

Investor

Alveron PharmaHaya TherapeuticsIsomab

Per curated public sources.

Colleagues at Broadview Ventures

Annabel Chen-Tournoux
Investor at Broadview Ventures
Anubodh Sunny Varshney
Venture Advisor at Broadview Ventures
Christopher Colecchi
Managing Director at Broadview Ventures
Christopher de Souza
Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Milan
Chief Scientific Officer, Leducq Corp at Broadview Ventures
David Prim
Principal at Broadview Ventures
Hewmun Lau
Principal at Broadview Ventures

Network5

Christopher Colecchi
Managing Director at Broadview Ventures
Daniel Gottlieb
Director at Broadview Ventures
David Prim
Principal at Broadview Ventures
Maria Berkman
Partner at Vensana Capital
Thomas Needham
Director, Head of the Biopharma Practice at Broadview Ventures

Investors connected to Benjamin in public investor directories — a warm-intro map.

Frequently asked questions

Who is Benjamin Kreitman?
Principal on the Biopharma team sharing responsibility for sourcing, diligence, and portfolio board work. Previously a consultant at Monitor Deloitte.
Where does Benjamin Kreitman work?
Benjamin Kreitman is Principal at Broadview Ventures.
What check size does Benjamin Kreitman write?
Benjamin Kreitman typically writes checks of $100K – $5M.
What companies has Benjamin Kreitman invested in?
Investments tracked here include Alveron Pharma, Haya Therapeutics, Isomab.
Where did Benjamin Kreitman go to school?
Benjamin Kreitman studied at Columbia University (Financial Economics, Biological Sciences).

Same school

Shared employers